KBI Biopharma Inc., a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), has appointed Jean-Baptiste (JB) Agnus as its Chief Business Officer.
KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
KBI Biopharma Strengthens Quality & RA Expertise Appointment of CQO
KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI’s expertise in Quality and Regulatory Affairs.
KBI Biopharma Recognized Leader All Six Categories of the 2024 CDMO Awards
KBI Biopharma and Argonaut Manufacturing Services Forge Strategic Alliance
KBI Biopharma Appoints Maggie Chen as Site Head of Patriot Park Mammalian cGMP
DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the recent appointment of Maggie Chen, Senior Vice President and Site Head of the Patriot Park mammalian cGMP manufacturing facility in Durham, North Carolina. She brings over 20 years of biopharmaceutical experience with a proven track record as a successful leader in Manufacturing, Manufacturing, Science & Technologies (MS&T), Quality, and Engineering. Chen now leverages her vast multi-disciplinary experience in leading the site’s day-to-day operations.
KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing